Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TGFBR1 | P36897 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL310237 | 0.85 | TGFBR1 (0.44) | TGFBR1 | |
| SCHEMBL3660408 | 0.83 | TGFBR1 (0.31) | TGFBR1 | |
| SCHEMBL3662683 | 0.83 | TGFBR1 (0.31) | TGFBR1 | |
| SCHEMBL11690191 | 0.83 | ALDH1A1 (0.43) | TGFBR1 | |
| SCHEMBL1561700 | 0.81 | TGFBR1 (0.44) | TGFBR1 | |
| SCHEMBL5013368 | 0.81 | TGFBR1 (0.49) | TGFBR1 | |
| Potassium Ion SCHEMBL3656408 | 0.81 | TGFBR1 (0.44) | TGFBR1 | |
| O-Tolylamine SCHEMBL11690194 | 0.81 | TDP1 (0.37) | TGFBR1 | |
| SCHEMBL8539211 | 0.80 | TSHR (0.34) | — | |
| SCHEMBL3656406 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1260 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8361484-B2 | Polymer systems for lung volume reduction therapy | AERIS THERAPEUTICS, INC. (US) | 2013-01-29 | — | — | US | claimed |
| US-20110244254-A1 | Anticorrosion coatings with reactive polyelectrolyte complex system | SONG ZHIQIANG | 2011-10-06 | — | — | US | claimed |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | CANADIAN IMPERIAL BANK OF COMMERCE (CA) | 2010-02-18 | — | — | US | claimed |
| EP-2059227-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | Aeris Therapeutics, Inc. (US) | 2009-05-20 | — | — | EP | claimed |
| WO-2008039827-A2 | POLYMER SYSTEMS FOR LUNG VOLUME REDUCTION THERAPY | AERIS THERAPEUTICS, INC. (US) | 2008-04-03 | — | — | WO | claimed |
| EP-1243564-B1 | Process for preventing formation of scale | KURITA WATER IND LTD (JP) | 2007-08-15 | — | — | EP | claimed |
| EP-1201720-B1 | Printing fluid additives promoting overcoat adhesion | HEWLETT PACKARD CO (US) | 2004-09-15 | — | — | EP | claimed |
| US-6656365-B2 | Within water cooling/supply systems, via ozone which is used for disinfection, and high molecular weight homo/copolymers of acrylic acid, methacyrlic acid, maleic acid, maleic anhydride, and itaconic acid | KURITA WATER INDUSTRIES LTD. (JP) | 2003-12-02 | — | — | US | claimed |
| US-6177197-B1 | INK RECEIVING LAYER IS A CROSSLINKED PRODUCT OF POLYVINYL ALCOHOL RESIN AND CARBODIIMIDE CROSSLINKING AGENT | NIPPON INDUSTRIES, INC. (JP) | 2001-01-23 | — | — | US | claimed |
| US-4319014-A | UNDATURATED CARBOXYLIC ACID COPOLYMER WITH UNDATURATED SULFONATE COMONOMER MODIFIED BY A MERCAPTAN | UNIROYAL, INC. (US) | 1982-03-09 | — | — | US | claimed |
| JP-57057705-A | — | — | None | — | — | JP | disclosed |
| JP-3093892-A | — | — | None | — | — | JP | disclosed |
| US-12617181-B2 | Multilayer structure, and packaging material for retort using same | KURARAY CO., LTD. (JP) | 2026-05-05 | — | — | US | disclosed |
| US-20260085184-A1 | ADHESIVE RESIN COMPOSITION | KURARAY CO., LTD. (JP) | 2026-03-26 | — | — | US | disclosed |
| EP-4715042-A1 | METHOD FOR PRODUCING CELLS | Kuraray Co., Ltd. (JP) | 2026-03-25 | — | — | EP | disclosed |
| EP-0003516-B1 | AQUOUS DISPERSIONS OF COPOLYMERS WITH CARBONYL GROUPS THAT CONTAIN HYDRAZINE DERIVATIVES AND HEAVY METAL IONS | BASF Aktiengesellschaft (DE) | 1981-04-01 | — | — | EP | disclosed |
| EP-0025979-A1 | Aqueous solution or dispersion of a styrene-maleic acid anhydride copolymer, process for its preparation and its use | HOECHST AKTIENGESELLSCHAFT (DE) | 1981-04-01 | — | — | EP | disclosed |
| US-4250070-A | ALSO CONTAINING HEAVY METAL IONS; STORAGE STABILITY; CROSSLINKING; COATINGS | BASF AKTIENGESELLSCHAFT (DE) | 1981-02-10 | — | — | US | disclosed |
| US-4008293-A | ACRYLIC COPOLYMER, AMINOPLAST, BINDER | PPG INDUSTRIES, INC. (US) | 1977-02-15 | — | — | US | disclosed |
| JP-S05757705-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12617181-B2 | Multilayer structure, and packaging material for retort using same | VMA21, PUF60, RBM39 | TGFBR1 2252/4885 |
| US-20100040538-A1 | Polymer Systems for Lung Volume Reduction Therapy | GFER, MUC1, CTH | TGFBR1 700/4885 |
| US-20260085184-A1 | ADHESIVE RESIN COMPOSITION | COL1A1, ICAM1, COL2A1 | TGFBR1 1656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.